Reckitt Spies Opportunity For Global Supplements Business
RB CEO Laxman Narasimhan sees the potential for the company to establish a global supplements business built on the successes it has enjoyed in the US and China. The comments came as RB reported solid growth in the third quarter, despite struggles for its OTC brands.
You may also be interested in...
Reckitt is refocusing its consumer health portfolio by offloading the troubled Scholl brand and acquiring fast-growing US topical analgesic Biofreeze.
Sweden's BioGaia is looking to capitalize on growing momentum in the US probiotics market with a number of launches. The firm's recent US growth helped to offset falling sales in its more established European markets during the first quarter.
A year on from the start of the COVID-19 outbreak and a global rush for supplements, Bayer has cemented these sales gains with slight growth at its Nutritionals business in Q1.